Below is a snippet from the Australian last month.This month Resmed lauches its new products, opening up new markets, so it should be good for its share price.
Interesting it sites obesity as a driver of its consumer base.
"Next month ResMed will launch five new products, including three masks and a generator targeted at the lower end of the market.
Mr Farrell said the machine would be 50 per cent cheaper than the existing devices, which were fully automated.
"It has fewer of the bells and whistles and will allow us to play in the value end of the market and that's a pretty big market in the US, Brazil and Spain.
"And our current masks are very good but they only fit about 80 per cent of our patients whereas these will fit 95 per cent of customers."
Mr Farrell believes the rising incidence of obesity and diabetes, which significantly increase the risk of sleeping disorders, will provide ResMed with an enormous customer base.
"We're signing deals with big trucking companies in the US. People are on the road, working long hours, not exercising, and eating horse manure and developing sleeping disorder.
"This market is worth billions and billions and billions of dollars."
Cheers
Oscar
RMD Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held